Literature DB >> 16125526

High-sensitive C-reactive protein, tumor necrosis factor alpha, and cardiovascular risk factors before and after weight loss in obese children.

Thomas Reinehr1, Birgit Stoffel-Wagner, Christian L Roth, Werner Andler.   

Abstract

To confirm the existence of obesity-induced inflammation and to clarify the association between such inflammation and other cardiovascular risk factors, we investigated the relationships between high-sensitive C-reactive protein (hsCRP), tumor necrosis factor alpha (TNF-alpha), obesity, blood pressure, lipids, and insulin resistance in a long-term follow-up of obese children. We compared the serum concentrations of hsCRP, TNF-alpha, high-density lipoprotein cholesterol, and triglycerides as well as blood pressure and the insulin resistance index (homeostasis model assessment [HOMA]) of 14 nonobese and 31 obese children. Furthermore, we studied the changes in these parameters in 16 obese children who lost weight and in 15 obese children without weight change over a 1-year period. In the obese children, blood pressure (P=.003), HOMA (P=.034), and triglyceride (P=.011), TNF-alpha (P=.015), and hsCRP (P<.001) levels were significantly higher, whereas high-density lipoprotein cholesterol concentrations were significantly (P=.015) lower compared with the nonobese children. Weight loss was associated with a significant decrease in hsCRP (P=.008) and triglyceride (P=.048) levels, HOMA (P<.001), and blood pressure (P=.019), whereas there were no significant changes in the children with stable weight status. The changes in hsCRP and TNF-alpha levels over the 1-year period were not significantly correlated to the changes in lipids, blood pressure, and HOMA. Obese children demonstrated significantly higher levels of hsCRP and TNF-alpha compared with nonobese children. The chronic inflammation markers TNF-alpha and hsCRP were independent of lipids, blood pressure, and insulin resistance index. Weight loss was associated with the significant decrease of hsCRP and triglyceride levels, and blood pressure.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16125526     DOI: 10.1016/j.metabol.2005.03.022

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  36 in total

1.  Colchicine to decrease NLRP3-activated inflammation and improve obesity-related metabolic dysregulation.

Authors:  Andrew P Demidowich; Angela I Davis; Nicket Dedhia; Jack A Yanovski
Journal:  Med Hypotheses       Date:  2016-04-25       Impact factor: 1.538

Review 2.  Obesity, systemic inflammation, and increased risk for cardiovascular disease and diabetes among adolescents: a need for screening tools to target interventions.

Authors:  Mark D DeBoer
Journal:  Nutrition       Date:  2012-09-28       Impact factor: 4.008

Review 3.  Exercise-based interventions and C-reactive protein in overweight and obese youths: a meta-analysis of randomized controlled trials.

Authors:  Antonio García-Hermoso; Mairena Sánchez-López; Yolanda Escalante; Jose M Saavedra; Vicente Martínez-Vizcaíno
Journal:  Pediatr Res       Date:  2015-12-21       Impact factor: 3.756

4.  A one-year school-based diet/exercise intervention improves non-traditional disease biomarkers in Mexican-American children.

Authors:  Brian Keith McFarlin; Craig J Johnston; Katie C Carpenter; Tiffany Davidson; Jennette L Moreno; Kelley Strohacker; Whitney L Breslin; John P Foreyt
Journal:  Matern Child Nutr       Date:  2012-03-28       Impact factor: 3.092

5.  Linkage between C-reactive protein and triglyceride-rich lipoprotein metabolism.

Authors:  Nuntakorn Thongtang; Margaret R Diffenderfer; Esther M M Ooi; Bela F Asztalos; Gregory G Dolnikowski; Stefania Lamon-Fava; Ernst J Schaefer
Journal:  Metabolism       Date:  2012-09-25       Impact factor: 8.694

6.  Fasting and postprandial markers of inflammation in lean and overweight children.

Authors:  Jessica A Alvarez; Paul B Higgins; Robert A Oster; José R Fernandez; Betty E Darnell; Barbara A Gower
Journal:  Am J Clin Nutr       Date:  2009-02-11       Impact factor: 7.045

7.  Leukocyte Count versus C-Reactive Protein Levels in Obese Portuguese Patients Aged 6-12 Years Old.

Authors:  Henrique Nascimento; Susana Rocha; Carla Rego; Helena Ferreira Mansilha; Alexandre Quintanilha; Alice Santos-Silva; Luís Belo
Journal:  Open Biochem J       Date:  2010-06-10

8.  Effect of obesity on response to cardiovascular drugs in pediatric patients with renal disease.

Authors:  Sherif Hanafy; Maury Pinsk; Fakhreddin Jamali
Journal:  Pediatr Nephrol       Date:  2008-12-13       Impact factor: 3.714

Review 9.  Cardiovascular disease in childhood: the role of obesity.

Authors:  Despina Herouvi; Evangelos Karanasios; Christina Karayianni; Kyriaki Karavanaki
Journal:  Eur J Pediatr       Date:  2013-01-23       Impact factor: 3.183

10.  Resting Heart Rate Variability, Inflammation, and Insulin Resistance in Overweight and Obese Adolescents.

Authors:  Roy C Parish; Steven Todman; Sushil K Jain
Journal:  Metab Syndr Relat Disord       Date:  2016-05-16       Impact factor: 1.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.